NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT00520936 2011-02-25A Study of Pemetrexed in Children With Recurrent CancerEli Lilly and CompanyPhase 2 Completed72 enrolled 17 charts